Legal Representation
Attorney
Chelsea E. Carbone
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 4, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 4, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 2, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Apr 2, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Apr 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 11, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 9, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 9, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 9, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 23, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 23, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 23, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 4, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 9, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 9, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 20, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 30, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 29, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 4, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in immunology, autoimmune disease, oncology, and infectious disease; pharmaceutical preparations for antibody and cellular immunotherapies
Class 042
Medical and scientific research in the fields of immunology, autoimmune disease, oncology, and infectious disease; research and development in the fields of antibody and cellular immunotherapies, and diagnostic tests; pharmaceutical research and development
Additional Information
Design Mark
The mark consists of two stylized intertwined circles to the left of a stylized "NEXTVIVO."
Pseudo Mark
NEXT VIVO
Classification
International Classes
005
042